This is unpublished

Drs. Ian de Boer, Michael Kelly, Matt Rivara, John Stivelman, Kleber Fertrin

December 19, 2025
Special In-person event at SLU-Brotman: 40th Anniversary of Erythropoietin use in Nephrology
Pinned

Special Session:
40th Anniversary of Erythropoietin Clinical Trials in Seattle

Part 1a Presentation:

Development of Erythropoietin: A Local History of Bedside-Bench-Bedside Innovation

Image removed.

Ian de Boer, MD, MS
Professor of Medicine
Division of Nephrology

 

 

Image removed.

 

Michael Kelly, MD
Clinical Professor Emeritus
Division of Nephrology

Part 1b Presentation:

Dialysis, Dollars, and Hemoglobin: The Evolution of ESA Therapy in ESKD in the United States

Image removed.

Matt Rivara, MD
Associate Professor of Medicine
Division of Nephrology

 

 

Image removed.

 

John Stivelman, MD
Professor Emeritus
Division of Nephrology

 

View part 1a and part 1b presentation here:

Part 2 Presentation:

Beyond EPO and Iron: Tricking The Oxygen Sensor In CKD Anemia

Image removed.

 

Kleber Yotsumoto Fertrin, MD, PhD
Associate Professor of Medicine
Division of Hematology and Oncology

 

View part 2 presentation here:

 

Matt Rivara, MD
Matthew Rivara MD
Associate Professor, Division of Nephrology
University of Washington
Chief Medical Officer, Northwest Kidney Centers
Ian de Boer, MD
Ian de Boer, MD, MS
Professor, Division of Nephrology
University of Washington
Joseph W. Eschbach Endowed Chair in Kidney Research
Director of Research, Nephrology
Director, Kidney Research Institute
Kleber Fertrin, MD
Kleber Yotsumoto Fertrin, MD, PhD
Associate Professor, Division of Hematology and Oncology
University of Washington School of Medicine
Director, Sickle Cell Disease and Iron Overload Program, Fred Hutch Cancer Center